S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|137|9|2093-2103

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.9, 2015-11, pp. : 2093-2103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract